Update on cryptogenic organizing pneumonia.
Radzikowska E, Fijolek J.
Front Med (Lausanne). 2023 Apr 20;10:1146782. doi: 10.3389/fmed.2023.1146782. eCollection 2023.
Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD).
Yamakawa H, Ogura T, Kameda H, Kishaba T, Iwasawa T, Takemura T, Kuwano K.
J Clin Med. 2021 Aug 25;10(17):3806. doi: 10.3390/jcm10173806.
[Drug-induced interstitial lung diseases].
Bonniaud P, Georges M, Favrolt N, Camus P.
Rev Prat. 2014 Sep;64(7):951-6.
Radiation-Induced Lung Injury-Current Perspectives and Management.
Rahi MS, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S, Subramaniyam R, Jeyashanmugaraja GP, Gunasekaran K.
Clin Pract. 2021 Jul 1;11(3):410-429. doi: 10.3390/clinpract11030056.
[Hydroxyurea-induced pneumonia].
Girard A, Ricordel C, Poullot E, Claeyssen V, Decaux O, Desrues B, Delaval P, Jouneau S.
Rev Mal Respir. 2014 May;31(5):430-4. doi: 10.1016/j.rmr.2013.09.001. Epub 2013 Oct 9.
Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
Min JH, Lee HY, Lim H, Ahn MJ, Park K, Chung MP, Lee KS.
Cancer Chemother Pharmacol. 2011 Nov;68(5):1099-109. doi: 10.1007/s00280-011-1737-2. Epub 2011 Sep 13.
Acute and subacute idiopathic interstitial pneumonias.
Taniguchi H, Kondoh Y.
Respirology. 2016 Jul;21(5):810-20. doi: 10.1111/resp.12786. Epub 2016 Apr 28.
Acute and subacute chemical-induced lung injuries: HRCT findings.
Akira M, Suganuma N.
Eur J Radiol. 2014 Aug;83(8):1461-9. doi: 10.1016/j.ejrad.2014.04.024. Epub 2014 May 1.
Drug-induced pneumonitis: the role of methotrexate.
Zisman DA, McCune WJ, Tino G, Lynch JP 3rd.
Sarcoidosis Vasc Diffuse Lung Dis. 2001 Oct;18(3):243-52.
Management of hypersensivity pneumonitis.
Agache IO, Rogozea L.
Clin Transl Allergy. 2013 Feb 4;3(1):5. doi: 10.1186/2045-7022-3-5.
